About Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. (REGN) is a publicly traded company in the Healthcare sector, specifically in the Biotechnology industry. View real-time stock data, AI analysis, options flow, and convergence signals for REGN on iGotFomo.
REGN Key Statistics
| Current Price | $748.87 | Market Cap | $79.2 billion |
|---|---|---|---|
| Daily Change | -2.47% | Volume | 751K |
| 52-Week High | $821.11 | 52-Week Low | $476.49 |
| P/E Ratio (TTM) | 18.05 | Forward P/E | 14.29 |
| Sector | Healthcare | Industry | Biotechnology |
Frequently Asked Questions About REGN
- What is Regeneron Pharmaceuticals, Inc. (REGN)?
- Regeneron Pharmaceuticals, Inc. (REGN) is a publicly traded company in the Healthcare sector, operating in the Biotechnology industry.
- What is the current REGN stock price?
- As of the latest trading session, REGN trades at $748.87 per share, with a daily change of -2.47%.
- What is REGN's market capitalization?
- Regeneron Pharmaceuticals, Inc. has a market capitalization of $79.2 billion, making it a large-cap stock.
- What sector does REGN belong to?
- Regeneron Pharmaceuticals, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry. View all Healthcare stocks.
